Accordingly, the potentiation of CYP/epoxygenase activity compensates for endothelial dysfunction in females, while the estrogen-dependent downregulation of EPHX2 expression yields divergent effects in the circulation (reviewed in [35]). The gene discussed is PPIG; the disease is endothelial dysfunction.